FIORENTINO, F.; CANALI, B.; MORELLI, P.; DEMMA, F. Brentuximab vedotin in combination with doxorubicin, vinblastine and dacarbazine for first-line treatment of stage IV HL: cost impact on subsequent lines in Italy. AboutOpen, [S. l.], v. 10, n. 1, p. 6–12, 2023. DOI: 10.33393/ao.2023.2486. Disponível em: https://journals.aboutscience.eu/index.php/aboutopen/article/view/2486. Acesso em: 23 nov. 2024.